265 related articles for article (PubMed ID: 11861833)
1. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
[TBL] [Abstract][Full Text] [Related]
2. A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
Wang X; Fang Z; Xiong J; Yang K; Chi Y; Tang X; Ma L; Zhang R; Deng F; Lan K; Zhou D
Virology; 2019 Oct; 536():32-38. PubMed ID: 31394410
[TBL] [Abstract][Full Text] [Related]
3. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice.
Xiang Z; Li Y; Gao G; Wilson JM; Ertl HC
J Immunol; 2003 Oct; 171(8):4287-93. PubMed ID: 14530353
[TBL] [Abstract][Full Text] [Related]
4. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.
Xiang ZQ; Gao GP; Reyes-Sandoval A; Li Y; Wilson JM; Ertl HC
J Virol; 2003 Oct; 77(20):10780-9. PubMed ID: 14512528
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
[TBL] [Abstract][Full Text] [Related]
6. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
7. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.
Wang Y; Xiang Z; Pasquini S; Ertl HC
J Virol; 1998 Mar; 72(3):1790-6. PubMed ID: 9499029
[TBL] [Abstract][Full Text] [Related]
8. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.
Wang Y; Xiang Z; Pasquini S; Ertl HC
J Virol; 1997 May; 71(5):3677-83. PubMed ID: 9094641
[TBL] [Abstract][Full Text] [Related]
9. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
Wang C; Dulal P; Zhou X; Xiang Z; Goharriz H; Banyard A; Green N; Brunner L; Ventura R; Collin N; Draper SJ; Hill AVS; Ashfield R; Fooks AR; Ertl HC; Douglas AD
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006870. PubMed ID: 30372438
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
[TBL] [Abstract][Full Text] [Related]
11. T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells.
Xiang ZQ; Gao GP; Li Y; Wilson JM; Ertl HC
Virology; 2003 Jan; 305(2):397-405. PubMed ID: 12573585
[TBL] [Abstract][Full Text] [Related]
12. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
[TBL] [Abstract][Full Text] [Related]
13. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal immunity with a replication-defective adenoviral recombinant.
Xiang Z; Ertl HC
Vaccine; 1999 Apr; 17(15-16):2003-8. PubMed ID: 10217600
[TBL] [Abstract][Full Text] [Related]
15. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
[TBL] [Abstract][Full Text] [Related]
16. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.
Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H
Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838
[TBL] [Abstract][Full Text] [Related]
17. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
Xiang ZQ; Greenberg L; Ertl HC; Rupprecht CE
Virology; 2014 Feb; 450-451():243-9. PubMed ID: 24503087
[TBL] [Abstract][Full Text] [Related]
18. Generation of an adenoviral vaccine vector based on simian adenovirus 21.
Roy S; Zhi Y; Kobinger GP; Figueredo J; Calcedo R; Miller JR; Feldmann H; Wilson JM
J Gen Virol; 2006 Sep; 87(Pt 9):2477-2485. PubMed ID: 16894185
[TBL] [Abstract][Full Text] [Related]
19. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
[TBL] [Abstract][Full Text] [Related]
20. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
